Namenda

Description overdue on 04.07.2012

Related Articles:

• Price Vitrum Antistress
• Fervex, instructions for use
• Bioparox, reviews about the drug
• Chondroitin sulfate

Tweet

Antiparkinsonian . The main component is memantine hydrochloride . The drug has antiparkinsonian, neuroprotection, antispastic effects. Namenda reduces the severity of symptoms depression , Fatigue, improves the patient's ability to concentrate, improves memory, promotes correction of motor disorders. Memantine hydrochloride after oral administration is rapidly absorbed, the maximum concentration of the basic substance is registered in 2-6 hours. Metabolites are the renal system. In the pathology of renal accumulation of the drug in the body does not occur. Namenda is available in tablet dosage form.

Indications:

Namenda is used for Parkinson's disease, in violation of the nervous system, fatigue, impaired memory, reduced ability to concentrate, loss of interest in activities, with spastic spinal and cerebral syndromes   (after a stroke, multiple sclerosis , Traumatic brain injury), Parkinsonism, with   dementia : Vascular, Alzheimer's, mixed.

Contraindications:

Namenda is not applicable in case of intolerance memantine hydrochloride, severe renal pathology system in confusion . In myocardial infarction, breast feeding, seizures, hyperthyroidism, pregnancy, epilepsy , Heart failure Namenda is used with caution.

Side effect:

Namenda can cause nausea, dizziness, fatigue, irritability, increased intracranial pressure, restlessness, fatigue, anxiety internally.

Mode of application:

The drug Namenda is used during the meal inside. Therapy begins with the minimum doses of 5 mg daily, then weekly dosage is increased by 5 mg. In the pathology of renal minimum prescribed dosage.

Special instructions:

Namenda affect the performance of a complex mental activity, to drive motor vehicles.

Drug Interactions:

Namenda enhances the action anticholinergics , Neuroleptics, barbiturates, bromocriptine . levodopa , Amantadine, dopamine agonists receptors. Can change action baclofen   and dantrolene.